Harvard Bioscience, Inc. (HBIO)
USD 0.37
(-3.78%)
USD 0.37
(-3.78%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 38.49 Million USD | -9.04% |
| 2022 | 42.31 Million USD | 4.46% |
| 2021 | 40.5 Million USD | 2.06% |
| 2020 | 39.69 Million USD | -12.73% |
| 2019 | 45.48 Million USD | -13.57% |
| 2018 | 52.62 Million USD | 774.85% |
| 2017 | 6.01 Million USD | -26.2% |
| 2016 | 8.15 Million USD | -32.95% |
| 2015 | 12.15 Million USD | 66.16% |
| 2014 | 7.31 Million USD | 816.55% |
| 2013 | -1.02 Million USD | 86.79% |
| 2012 | -7.73 Million USD | -378.4% |
| 2011 | -1.61 Million USD | 4.44% |
| 2010 | -1.69 Million USD | 48.24% |
| 2009 | -3.26 Million USD | 73.39% |
| 2008 | -12.27 Million USD | -21.06% |
| 2007 | -10.14 Million USD | -59.54% |
| 2006 | -6.35 Million USD | -815.07% |
| 2005 | 889 Thousand USD | -66.74% |
| 2004 | 2.67 Million USD | -46.14% |
| 2003 | 4.96 Million USD | 134.91% |
| 2002 | -14.21 Million USD | 42.81% |
| 2001 | -24.85 Million USD | 30.59% |
| 2000 | -35.8 Million USD | -731.44% |
| 1999 | 5.67 Million USD | 692.59% |
| 1998 | -957 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 37.1 Million USD | -3.59% |
| 2024 Q2 | 37.4 Million USD | 0.79% |
| 2023 Q2 | 37.09 Million USD | -7.86% |
| 2023 Q3 | 33.4 Million USD | -9.96% |
| 2023 Q4 | 38.49 Million USD | 15.23% |
| 2023 Q1 | 40.26 Million USD | -4.85% |
| 2023 FY | 38.49 Million USD | -9.04% |
| 2022 Q4 | 42.31 Million USD | -4.07% |
| 2022 FY | 42.31 Million USD | 4.46% |
| 2022 Q1 | 51.84 Million USD | 27.97% |
| 2022 Q2 | 52.13 Million USD | 0.57% |
| 2022 Q3 | 44.11 Million USD | -15.4% |
| 2021 Q3 | 39.66 Million USD | -13.66% |
| 2021 FY | 40.5 Million USD | 2.06% |
| 2021 Q1 | 46.97 Million USD | 18.35% |
| 2021 Q2 | 45.93 Million USD | -2.21% |
| 2021 Q4 | 40.5 Million USD | 2.14% |
| 2020 Q1 | 43.2 Million USD | -5.01% |
| 2020 Q2 | 41.09 Million USD | -4.87% |
| 2020 Q3 | 40.67 Million USD | -1.04% |
| 2020 Q4 | 39.69 Million USD | -2.41% |
| 2020 FY | 39.69 Million USD | -12.73% |
| 2019 FY | 45.48 Million USD | -13.57% |
| 2019 Q2 | 60.89 Million USD | -2.83% |
| 2019 Q1 | 62.67 Million USD | 19.1% |
| 2019 Q4 | 45.48 Million USD | -4.2% |
| 2019 Q3 | 47.47 Million USD | -22.04% |
| 2018 Q1 | 56.99 Million USD | 847.48% |
| 2018 FY | 52.62 Million USD | 774.85% |
| 2018 Q4 | 52.62 Million USD | -3.24% |
| 2018 Q3 | 54.38 Million USD | -2.58% |
| 2018 Q2 | 55.82 Million USD | -2.05% |
| 2017 FY | 6.01 Million USD | -26.2% |
| 2017 Q3 | 6.6 Million USD | -22.06% |
| 2017 Q2 | 8.47 Million USD | -6.43% |
| 2017 Q1 | 9.05 Million USD | 11.09% |
| 2017 Q4 | 6.01 Million USD | -8.91% |
| 2016 Q1 | 12.97 Million USD | 6.72% |
| 2016 FY | 8.15 Million USD | -32.95% |
| 2016 Q3 | 9.69 Million USD | -22.62% |
| 2016 Q2 | 12.53 Million USD | -3.4% |
| 2016 Q4 | 8.15 Million USD | -15.95% |
| 2015 Q3 | 14.06 Million USD | 6.13% |
| 2015 Q1 | 13.86 Million USD | 89.57% |
| 2015 FY | 12.15 Million USD | 66.16% |
| 2015 Q2 | 13.24 Million USD | -4.48% |
| 2015 Q4 | 12.15 Million USD | -13.54% |
| 2014 Q3 | -3.53 Million USD | 15.54% |
| 2014 Q2 | -4.18 Million USD | -79.03% |
| 2014 Q4 | 7.31 Million USD | 307.02% |
| 2014 Q1 | -2.33 Million USD | -128.89% |
| 2014 FY | 7.31 Million USD | 816.55% |
| 2013 FY | -1.02 Million USD | 86.79% |
| 2013 Q4 | -1.02 Million USD | 92.4% |
| 2013 Q3 | -13.43 Million USD | -36.38% |
| 2013 Q2 | -9.84 Million USD | -12.56% |
| 2013 Q1 | -8.74 Million USD | -13.17% |
| 2012 Q2 | -2.55 Million USD | -484.67% |
| 2012 Q3 | -4.98 Million USD | -95.11% |
| 2012 Q1 | -437 Thousand USD | 72.96% |
| 2012 Q4 | -7.73 Million USD | -55.09% |
| 2012 FY | -7.73 Million USD | -378.4% |
| 2011 FY | -1.61 Million USD | 4.44% |
| 2011 Q4 | -1.61 Million USD | -2476.47% |
| 2011 Q3 | 68 Thousand USD | 101.47% |
| 2011 Q2 | -4.64 Million USD | -55.86% |
| 2011 Q1 | -2.97 Million USD | -76.05% |
| 2010 Q1 | -5.23 Million USD | -60.09% |
| 2010 Q2 | -4.56 Million USD | 12.81% |
| 2010 Q3 | 795 Thousand USD | 117.43% |
| 2010 FY | -1.69 Million USD | 48.24% |
| 2010 Q4 | -1.69 Million USD | -312.7% |
| 2009 Q3 | -5.6 Million USD | 65.53% |
| 2009 Q1 | -14.92 Million USD | -21.52% |
| 2009 FY | -3.26 Million USD | 73.39% |
| 2009 Q4 | -3.26 Million USD | 41.73% |
| 2009 Q2 | -16.26 Million USD | -9.03% |
| 2008 Q3 | -9.44 Million USD | 19.2% |
| 2008 Q1 | -10.14 Million USD | -0.04% |
| 2008 FY | -12.27 Million USD | -21.06% |
| 2008 Q4 | -12.27 Million USD | -29.94% |
| 2008 Q2 | -11.69 Million USD | -15.26% |
| 2007 FY | -10.14 Million USD | -59.54% |
| 2007 Q4 | -10.14 Million USD | 7.72% |
| 2007 Q3 | -10.99 Million USD | -25.33% |
| 2007 Q2 | -8.76 Million USD | -23.42% |
| 2007 Q1 | -7.1 Million USD | -11.77% |
| 2006 Q4 | -6.35 Million USD | -57.08% |
| 2006 FY | -6.35 Million USD | -815.07% |
| 2006 Q3 | -4.04 Million USD | -132.32% |
| 2006 Q2 | -1.74 Million USD | -30.98% |
| 2006 Q1 | -1.33 Million USD | -249.61% |
| 2005 Q4 | 889 Thousand USD | -72.67% |
| 2005 Q2 | 1.98 Million USD | -30.94% |
| 2005 Q3 | 3.25 Million USD | 64.13% |
| 2005 FY | 889 Thousand USD | -66.74% |
| 2005 Q1 | 2.87 Million USD | 7.37% |
| 2004 FY | 2.67 Million USD | -46.14% |
| 2004 Q4 | 2.67 Million USD | -56.55% |
| 2004 Q3 | 6.15 Million USD | -19.47% |
| 2004 Q1 | 10.01 Million USD | 101.71% |
| 2004 Q2 | 7.63 Million USD | -23.69% |
| 2003 Q3 | -7.14 Million USD | -177.26% |
| 2003 FY | 4.96 Million USD | 134.91% |
| 2003 Q1 | -2.27 Million USD | 83.97% |
| 2003 Q2 | -2.57 Million USD | -13.13% |
| 2003 Q4 | 4.96 Million USD | 169.46% |
| 2002 Q1 | -25.61 Million USD | -3.07% |
| 2002 FY | -14.21 Million USD | 42.81% |
| 2002 Q2 | -26.22 Million USD | -2.38% |
| 2002 Q4 | -14.21 Million USD | 43.98% |
| 2002 Q3 | -25.37 Million USD | 3.26% |
| 2001 FY | -24.85 Million USD | 30.59% |
| 2001 Q2 | -31.13 Million USD | 26.53% |
| 2001 Q3 | -30.11 Million USD | 3.29% |
| 2001 Q1 | -42.38 Million USD | -18.36% |
| 2001 Q4 | -24.85 Million USD | 17.46% |
| 2000 FY | -35.8 Million USD | -731.44% |
| 2000 Q4 | -35.8 Million USD | 0.0% |
| 1999 FY | 5.67 Million USD | 692.59% |
| 1998 FY | -957 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -1391.282% |
| AngioDynamics, Inc. | -70.14 Million USD | 154.874% |
| AtriCure, Inc. | -9.81 Million USD | 492.115% |
| Avinger, Inc. | 10.12 Million USD | -280.336% |
| Azenta, Inc. | -618.47 Million USD | 106.223% |
| BioLife Solutions, Inc. | 7.25 Million USD | -430.677% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 98.428% |
| Daxor Corporation | 755.65 Thousand USD | -4993.567% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 2718.367% |
| Femasys Inc. | -15.01 Million USD | 356.34% |
| GlucoTrack, Inc. | -4.29 Million USD | 995.95% |
| Hologic, Inc. | 374.4 Million USD | 89.72% |
| ICU Medical, Inc. | 1.45 Billion USD | 97.346% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 101.447% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 646.957% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 843.912% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 997.737% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 997.737% |
| Masimo Corporation | 804 Million USD | 95.213% |
| Microbot Medical Inc. | -2.28 Million USD | 1783.727% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 501.115% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 87.264% |
| Nephros, Inc. | -2.47 Million USD | 1657.669% |
| NovoCure Limited | 355.42 Million USD | 89.171% |
| NEXGEL, Inc. | 98 Thousand USD | -39175.51% |
| NEXGEL, Inc. | 98 Thousand USD | -39175.51% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 34.823% |
| OraSure Technologies, Inc. | -276.9 Million USD | 113.9% |
| Pro-Dex, Inc. | 10.91 Million USD | -252.602% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 209.281% |
| Predictive Oncology Inc. | -5.87 Million USD | 755.501% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -1170.64% |
| QuidelOrtho Corporation | 2.49 Billion USD | 98.457% |
| Repligen Corporation | -39.51 Million USD | 197.396% |
| Sanara MedTech Inc. | 6.64 Million USD | -479.242% |
| STAAR Surgical Company | -147.2 Million USD | 126.147% |
| Sharps Technology, Inc. | -3.01 Million USD | 1377.503% |
| Utah Medical Products, Inc. | -92.52 Million USD | 141.599% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 98.041% |
| Jin Medical International Ltd. | -2.81 Million USD | 1466.586% |